Journal of Hepatology
@JHepatology
Followers
18,643
Following
1,214
Media
5,748
Statuses
16,411
Official journal of @EASLnews Geneva/Switzerland - RT ≠ endorsement - IF: 25.7 #hepatology #medicine #liver #healthcare #liverdisease
Geneva, Switzerland
Joined October 2012
Don't wanna be here?
Send us removal request.
Explore trending content on Musk Viewer
Drake
• 1944526 Tweets
Kendrick
• 1763353 Tweets
Lando
• 468609 Tweets
LISA TEAM REDBULL
• 446551 Tweets
#GranHermano
• 240064 Tweets
GW最終日
• 205483 Tweets
Furia
• 184850 Tweets
Menotti
• 150545 Tweets
Stars
• 141326 Tweets
MARTIN AL 9009
• 126634 Tweets
McLaren
• 102404 Tweets
Drizzy
• 100470 Tweets
Mauro
• 97710 Tweets
連休最終日
• 68431 Tweets
Bahia
• 66528 Tweets
Panamá
• 65934 Tweets
Mulino
• 55595 Tweets
FEDERICO
• 42215 Tweets
ゴールデンウィーク最終日
• 41439 Tweets
Juliana
• 35503 Tweets
#この漫画知っている人で100いいね
• 31650 Tweets
Tom Brady
• 23234 Tweets
Whitney
• 21488 Tweets
TERROR COM A ANA
• 19657 Tweets
Lombana
• 16839 Tweets
Larson
• 14401 Tweets
Del Moro
• 13070 Tweets
ゴムの日
• 11215 Tweets
#NASCAR
• 10240 Tweets
Pinned Tweet
📢Check our April issue ‼️
💥Featured article: A new clinical and prognostic characterization of the patterns of decompensation of cirrhosis🔗
Full issue here👉
#LiverTwitter
@ProfPaoloAngeli
@EASLedu
@EASLnews
1
18
47
📢NEW
@EASLnews
Clinical Practice Guidelines on acute-on-chronic liver failure
Available here:
2
168
349
🎉We are thrilled to announce that our new Impact Factor is 30.1🎉
👏Thanks to the Editorial Team, untiring peer reviewers & very innovative authors❕
@ProfPaoloAngeli
@EASLnews
@EASLedu
#LiverTwitter
12
47
275
🆕
@EASLnews
Clinical Practice Guidelines on the management of hepatic encephalopathy, in press‼️
Direct link👉
@EASLedu
@RautouE
@mromerogomez
@MontagneseSara
@DebbieShawcros1
#LiverTwitter
3
118
230
We are thrilled to announce that our new impact factor is 25.083!
Thanks to the editorial team, untiring peer reviewers and very innovative authors!
@ProfPaoloAngeli
@EASLnews
@EASLedu
17
29
207
#Anticoagulation
improves survival in patients with
#cirrhosis
and
#portalveinthrombosis
➡️The IMPORTAL competing-risk meta-analysis
Read it here👉
@Guerrero_A_
#LiverTwitter
0
76
199
🆕
@EASLnews
Clinical Practice Guidelines on the management of cystic liver diseases‼️
Direct link👉
@EASLedu
@joostphdrenth
@torra_roser
#LiverTwitter
1
86
180
We’re happy to announce our new 2019 Journal Impact Factor of 20.582 (up from 18.946). Thanks to our authors, readers, and editorial board for this amazing achievement!
@RajivJalan1
@ProfPaoloAngeli
@EASLnews
8
31
175
📢HEAL study❗️
Weekly
#albumin
infusion in individuals with
#cirrhosis
improved
✅quality of life
✅endothelial dysfunction
✅inflammation
➡️albumin levels & cognitive benefit persisted after ending infusions
Read it here👉
@JasmohanBajaj
#LiverTwitter
0
60
160
🆕
@EASLnews
Clinical Practice Guidelines on the management on sclerosing cholangitis, in press‼️
Direct link👉
@EASLedu
@tomhemmingk
@DrCynthiaLevy
#LiverTwitter
0
72
155
🆕Review❕
IgG4-related cholangitis - a mimicker of fibrosing and malignant cholangiopathies
🔓
#OpenAccess
at👉
#LiverTwitter
0
53
140
📢New nomenclature & diagnostic criteria for
#fattyliverdisease
agreed by global consensus❗️
➡️
#MASLD
: metabolic dysfunction-associated steatotic liver disease
✅non-stigmatising
✅can improve awareness & patient identification
🔓
#OpenAcces
👉
3
71
138
🆕Article in press❕
#Anticoagulation
improves survival in patients with
#cirrhosis
and
#portalveinthrombosis
: The IMPORTAL competing-risk meta-analysis
Read it here👉
@Guerrero_A_
#LiverTwitter
1
48
138
🆕2022 update from the
@BCLC_group
‼️
BCLC strategy for prognosis prediction & treatment recommendation Barcelona Clinic Liver Cancer (BCLC) staging system.
🆓🆓
🎉Just in time for the BCLC 35th anniversary celebration today🎉
🔗
0
68
131
🆕
#CPG
in press❕
EASL-ILCA Clinical Practice Guidelines on the management of
#IntrahepaticCholangiocarcinoma
🆓Find it here👉
@EASLedu
@EASLnews
#iCCA
#LiverTwitter
1
61
130
#Carvedilol
➡️non-selective #βblocker
✅associated with reduced risk of decompensating events
➡️improved survival in patients with
#cirrhosis
&
#portalhypertension
Read it here👉
#LiverTwitter
1
46
118
📢New nomenclature & diagnostic criteria for
#fattyliverdisease
agreed by global consensus
Joint publication with
@alehlatam
&
@AASLDtweets
❗️
Find the final version here👉
@EASLnews
@EASLedu
#LiverTwitter
0
55
116
#Carvedilol
➡️non-selective #βblocker
✅associated with reduced risk of decompensating events
➡️improved survival in patients with
#cirrhosis
&
#portalhypertension
Read it here👉
#LiverTwitter
1
39
107
New Review "Combined hepatocellular-cholangiocarcinoma: An update"
Read at
#worldcancerday2021
#livercancer
0
49
105
📢HEAL study❗️
Weekly
#albumin
infusion in individuals with
#cirrhosis
improved
✅quality of life
✅endothelial dysfunction
✅inflammation
➡️albumin levels & cognitive benefit persisted after ending infusions
Read it here👉
@JasmohanBajaj
#LiverTwitter
0
34
106
In people with type 2 diabetes:
➡️
#NAFLD
prevalence: 65%
➡️
#Fibrosis
prevalence: 14%
➡️
#Cirrhosis
prevalence: 6% (
➡️Obesity amplifies the risk of NAFLD and advanced fibrosis
Full text👉
@DrLoomba
#LiverTwitter
1
57
102
🆕EXPERT OPINION
The use of
#anticoagulants
in
#cirrhosis
➡️A major research gap
By
@marcosenzolo
&
@jcgarciapagan
Read it here👉
#LiverTwitter
0
38
99
🆕REVIEW❕
Inflammatory bowel disease and primary sclerosing cholangitis
➡️One disease or two❓
🔓
#OpenAccess
at👉
#LiverTwitter
0
34
98
#livertwitter
don't miss our November snapshot 👉 "The 6 C's of primary sclerosing cholangitis"
#PSC
✍️
@themayadeeb
, Tom H. Karlsen &
@AutoImmuneLiver
0
28
87
🆕Article in press❕
A new clinical and prognostic characterization of the patterns of decompensation of cirrhosis
#OpenAccess
here👉
@ProfPaoloAngeli
#LiverTwitter
1
43
84
📢Our new Impact Factor is 25.7🎉
🌟
@JHepatology
now ranks number 4 in our field🌟
👏Thanks to the Editorial Team, untiring peer reviewers & very innovative authors❕
@ProfPaoloAngeli
@EASLnews
@EASLedu
#LiverTwitter
2
10
84
🆕EXPERT OPINION❕
Fluid Resuscitation in Patients with
#Cirrhosis
and
#Sepsis
: A Multidisciplinary Perspective
By François Durand,
@kellumja
&
@mitra_nad
Read it here👉
#LiverTwitter
0
44
85
🆕EASL Clinical Practice Guidelines on
#haemochromatosis
in press‼️
Direct link👉
@EASLedu
@EASLnews
#LiverTwitter
1
37
80
In Press | A placebo-controlled randomised trial of budesonide for primary biliary
#cholangitis
following an insufficient response to UDCA by Gideon Hirschfield
@AutoImmuneLiver
& colleagues,
#openaccess
at
1
37
82
Expert Opinion | A new definition for metabolic associated
#fattyliver
disease: an international expert consensus statement
@phil_newsome7
@QAnstee
@dufour_jf
@mromerogomez
1
44
80
Hepatology Snapshot |
#Hepatic
#fibrosis
: A convergent response to
#liverinjury
that is reversible by Shuang Wang & Scott L Friedman
@MountSinaiNYC
1
35
79
🆕
#CPG
in press❕
EASL Clinical Practice Guidelines on
#ACLF
🆓Find it here👉
@EASLedu
@EASLnews
#acuteonchronicliverfailure
#LiverTwitter
0
34
81
📢Latest evidence on
#cardiovascular
evaluation of
#LiverTransplantation
candidates
➡️
#IschaemicHeartDisease
➡️
#AtrialFibrillation
& other arrhythmias
➡️
#ValvularHeartDisease
➡️
#Cardiomyopathies
🆓
@LisaVWMD
@kymwatt
@elizabeth_verna
#livertwitter
0
41
80
How can manipulation of
#gutmicrobiota
be used as a novel treatment approach for
#liverdisease
❓
Find out more here👉
By
@JasmohanBajaj
& colleagues
Part of
#BreakthroughsInHepatology
➡️
#LiverTwitter
0
32
80
New Expert Opinion by
@jaumebosch9
"Small diameter TIPS should lead to safely expanding the use of TIPS"
#openaccess
at
#LiverTwitter
4
30
77
📢Experts & advocates have spoken!
🚫No more "nonalcoholic" and "fatty"!
👏Welcome "Metabolic Dysfunction-Associated Steatotic Liver Disease (
#MASLD
)"👏
✅Embracing a variety of causes❗️
#NewNomenclature
👉
@EASLnews
@EASLedu
2
37
77
🆕EASL Clinical Practice Guidelines❕
➡️On prevention and management of bleeding and
#thrombosis
in patients with
#cirrhosis
Find out more here👉
@EASLedu
@EASLnews
#LiverTwitter
0
38
77
📢Study supports changing names & definitions of NAFLD & NASH to combat stigma❗️
➡️
#MASLD
: metabolic dysfunction-associated steatotic liver disease
➡️
#MetALD
: MASLD➕increased alcohol intake
🔓
#OpenAcces
👉
@AASLDtweets
@EASLnews
@alehlatam
#LiverTwitter
1
31
75
🆕
#CPG
in press❕
EASL Clinical Practice Guidelines on the management of
#liverdiseases
in
#pregnancy
🆓Find it here👉
@EASLedu
@EASLnews
#LiverTwitter
0
38
74
🆕2022 update from the
@BCLC_group
Strategy for prognosis prediction & treatment recommendation of
#HCC
✅All dimensions of a patient’s profile are taken into account
✅Expert clinical decision-making process
Read the update here👉
#LiverTwitter
0
37
72
2 distinct categories of patients with
#NAFLD
1⃣Metabolic component
➡️metabolic substrate surplus
2⃣Genetic component
➡️increased hepatic mitochondrial redox state
➡️reduced de novo lipogenesis & lipid export
#OpenAcces
at👉
#LiverTwitter
1
23
72
📢In this study
@MajaThiele
and colleagues assess the ability of biomarkers to predict the risk of developing symptomatic
#liverdisease
in patients with early stages of alcohol-related liver disease
🔓
#OpenAccess
at👉
1
27
71
Medical therapy of
#HCC
✅requires a multidisciplinary team
➡️longitudinally re-evaluates therapeutic strategies
➡️adapts therapeutic strategies
See this snapshot for more👉
#LiverTwitter
4
31
71
The IMPORTAL competing-risk meta-analysis:
➡️
#Anticoagulation
reduces all-cause and liver-related mortality in patients with
#cirrhosis
and
#portalveinthrombosis
(PVT)
🔓
#OpenAccess
at👉
@Guerrero_A_
#LiverTwitter
0
21
70
📢NEW, hot off the press!
A multi-society Delphi consensus statement on new fatty liver disease nomenclature
in a joint publication with
@alehlatam
@aasld
#LiverTwitter
@EASLnews
@AASLDtweets
1
34
69
📢Our September issue is out ‼️
Featured article:
➡️A global research priority agenda to advance
#publichealth
responses to
#fattyliver
disease
Full issue➡️
2
29
67
Clinical trial of
#obeticholicacid
(OCA) in patients with NASH (REGENERATE)
OCA:
➡️superior to placebo in improving
#fibrosis
by ≥1 stage (no worsening of NASH)
➡️reduced liver stiffness compared to placebo
➡️well tolerated
🔗
#OpenAccess
#LiverTwitter
1
23
67
Worldwide study:
Corticosteroids improve 30-day survival among patients with severe alcohol-associated
#hepatitis
, especially with MELD scores between 25 and 39
By
@juanpabloarab
&
@LuisAntonioDiaz
& colleagues➡️
0
20
66
The new
@EASLedu
guidelines on on non-invasive tests are now available
#livertwitter
#ebm
@docberza
@RautouE
@salvatore_petta
@ldcastera
@MajaThiele
3
29
65
Experts & advocates unite for CHANGE in
#liverdisease
terminology!🤝
Say goodbye to NAFLD & NASH and welcome "Metabolic Dysfunction-Associated Steatotic Liver Disease (
#MASLD
)" as the new name❗️
Find out more here👉
@EASLnews
@EASLedu
#LiverTwitter
0
23
66
🆕Article in press❕
Metformin reduces
#hepatocellularcarcinoma
incidence after successful antiviral therapy in patients with diabetes and chronic
#hepatitisC
in Taiwan
Read it here👉
#LiverTwitter
0
20
65
📢Our August issue is out❗️
Featured article:
➡️Using the
#ELFtest
, FIB-4 and
#NAFLD
#fibrosis
score to screen the population for
#liverdisease
🔗
Full issue➡️
#LiverTwitter
0
26
66
#NAFLD
affects approximately 30% of people worldwide and appears to be increasing❗️
➡️Males & overweight/obese individuals had significantly higher incidence rates compared🆚females & those of normal weight
Read it here👉
#LiverTwitter
0
27
65
Now available the latest
@EASLnews
Clinical Practice Guidelines on
#nutrition
in chronic
#liver
#disease
@docberza
#cirrhosis
1
46
65
🆕Review❕
Incretins (GLP1 r agonists and dual, triple agonists) and the liver
🔓
#OpenAccess
at👉
#LiverTwitter
0
28
64
🆕2022 update from the
@BCLC_group
Strategy for prognosis prediction & treatment recommendation of
#HCC
✅All dimensions of a patient’s profile are taken into account
✅Expert clinical decision-making process
Read the update here👉
#LiverTwitter
0
35
61
🆕
#CPG
in press❕
EASL-ILCA Clinical Practice Guidelines on the management of
#IntrahepaticCholangiocarcinoma
🆓Find it here👉
@EASLedu
@EASLnews
#iCCA
#LiverTwitter
0
29
63
October's Snapshot "Primary biliary
#cholangitis
: a multifaceted pathogenesis with potential therapeutic targets" by
@pinvernizzi70
@MCarbone_80
@AlessioGerussi
@lalicristos
@ronca_vincenzo
@unimib
#PCB
1
29
62
Metabolic disturbances caused by
#HCV
➡️can persist after successful treatment
➡️can be a risk for development of
#LiverCancer
🔓
#OpenAccess
at👉
@FibrosisLab
@J__Leslie
@derekamann1
@MikeVacca1979
#LiverTwitter
1
29
63
🆕Article in press❕
Plasma ammonia levels predict hospitalisation with liver-related complications and mortality in clinically stable outpatients with
#cirrhosis
🔓
#OpenAccess
at👉
@thomastranah
@mapibafe
@DebbieShawcros1
@RajivJalan1
#LiverTwitter
1
28
63
🆕REVIEW❕
#CombinationImmunotherapy
for
#hepatocellularcarcinoma
By
@LorenzaRimassa
, Richard S. Finn & Bruno Sangro
Read it here👉
#LiverTwitter
0
27
63
Image of an ideal experimental model of
#NAFLD
/
#NASH
. Read an overview of the mostly used models of chronic
#liverdisease
, their reproducibility and practicality, advantages and weaknesses in this recent review by
@JSGracia
#cirrhosis
#livercancer
0
31
62
🆕Hepatology Snapshot❕
Pathogenesis of primary liver carcinomas
By
@valerieparadis
&
@Zucmanrossi
Find it here👉
#PrimaryLiverCancer
#HCC
#CCA
#LiverTwitter
0
25
62
🆕Article in press❕
The novel SALT-M score predicts 1-year post-transplant mortality in patients with severe
#acuteonchronicliverfailure
Read it here👉
@ruben_hernaez
#LiverTwitter
0
24
62
📢Maternal obesity increases the risk & severity of
#NAFLD
in offspring
Swedish nationwide cohort study by
@hanneshagstrom
& colleagues
🔓
#OpenAccess
here👉
1
18
62
Patients achieving
#SVR
experienced a progressive reduction in portal pressure during follow-up, however, clinically significant
#portal
#hypertension
persists in >50% of patients.
@SaSi_Lens
,
@jaumebosch9
1
16
62
🆕REVIEW❕
Endoscopic procedures in
@hepatology
➡️Current trends and new developments
Read it here👉
#LiverTwitter
0
30
62
With an Impact Factor of 14.911,
@JHepatology
has achieved his best IF ever!
A special thanks to our editors, reviewers, authors and readers!
1
20
61
📢Check out this month's Hepatology Snapshot‼️
Discover the astonishing number of
✅structural
✅functional
✅embryological variation
within the ductular network of the biliary tree
🔗
#Cholangiopathies
#biliary
0
19
60
Read more on the impact of non-selective beta-blockers in cirrhotic patients with refractory ascites in this study by
@luistevilla
, A Albillos and colleagues at
#livertwitter
#cirrhosis
.
2
26
61
New Hepatology Snapshot | Primary biliary
#cholangitis
: a multifaceted pathogenesis with potential therapeutic targets by Marco Carbone, Pietro Invernizzi and colleagues
@unimib
2
31
58
🆕Article in press❕
Multidrug-resistant bacterial infections after liver transplantation: prevalence, impact, and risk factors
Full text here👉
#LiverTwitter
3
23
61
📢Check our January issue ‼️
Featured article:
➡️A prospective, multicenter, three-cohort study evaluating contrast-induced
#acutekidneyinjury
(CI-AKI) in patients with
#cirrhosis
🔗
Full issue👉
#LiverTwitter
@EASLnews
@EASLedu
0
20
60
🆕Hepatology Snapshot❕
Pathogenesis of primary liver carcinomas
By
@valerieparadis
&
@Zucmanrossi
Find it here👉
#PrimaryLiverCancer
#HCC
#CCA
#LiverTwitter
0
35
59
🆕Article in press❕
Global burden of primary
#livercancer
in 2020 and predictions to 2040
🔓
#OpenAccess
at👉
@HarrietJR_
#LiverTwitter
0
22
59
#mafld
has been diagnosed based on the exclusion of other chronic liver diseases. Mohammed Eslam,
@phil_newsome7
,
@VladRatziu
and other international experts propose a new definition for the
#diagnosis
of MAFLD
#liverdisease
#livertwitter
3
20
58
👋
#LiverTwitter
What is your diagnosis❓
Patient: 53 years old
➡️Reporting 3 weeks of general malaise, fever, chills & sweats
Blood tests:
➡️Alkaline phosphatase 649 U/L
➡️GGT 804 U/L
➡️AST 65 U/L
➡️ALT 143 U/L
➡️Br 3.6 mg/dL
➡️CRP 9.78 mg/dl
1
15
59
🆕Article in press❕
TIPS prevents further decompensation and improves survival in patients with
#cirrhosis
and
#portalhypertension
in an individual patient data meta-analysis
Read it here👉
#LiverTwitter
0
26
59
🆕Article in press❕
A double-blind randomized placebo-controlled trial of albumin in patients with
#hepaticencephalopathy
: HEAL study
Read it here👉
@JasmohanBajaj
#LiverTwitter
0
19
58
🆕Article in press❕
Predicting survival in patients with ‘non-high-risk’ acute variceal bleeding receiving β-blockers+ligation to prevent re-bleeding
Read it here👉
@balcar_lorenz
@MattiasMandorf1
#LiverTwitter
0
19
58
The Journal of Hepatology reached 10,000 followers on twitter. 🙌 A big thanks to all our followers! Stay tuned, you will continue to find the latest developments and news in
#hepatology
right here.
#livertwitter
#liverdisease
1
3
57
🆕Article in press❕
Nestin as a diagnostic and prognostic marker for combined
#hepatocellular
-
#cholangiocarcinoma
Read it here👉
@Caldera60373705
#LiverTwitter
3
28
56
🆕Article in press❕
BAVENO VII - RENEWING CONSENSUS IN PORTAL HYPERTENSION
Read it here👉
#Cirrhosis
#LiverTwitter
0
26
55
🆕MEETING REPORT❕
International Liver cancer Association (ILCA) White Paper on
#HepatocellularCarcinoma
Risk Stratification and Surveillance
Read it here👉
@docamitgs
#LiverTwitter
0
17
57
📢Dietary supplementation with
#VitaminB12
&
#folate
could have therapeutic potential for the prevention/treatment of
#NonAlcoholicSteatohepatitis
➡️Based on studies in mice, primates & humans
🔓
#OpenAccess
at👉
#LiverTwitter
0
19
54
From our August issue | Animal models are crucial for improving our understanding of human pathogenesis. This review by
@JSGracia
@NevzorovaYulia
et al provides a comprehensive summary of the most widely used experimental models of chronic
#liverdisease
.
0
18
53
#COVID19
is higher in liver transplant patients but mortality is lower & immunosuppression withdrawal may not be justified. Read the algorithm to modify immunosuppression in LT patients with COVID by
@SETHepatico
,
@ColmeneroJordi
,
@CFondevila
& al. at .
2
21
55
Porto-sinusoidal vascular disorder (
#PSVD
)
➡️Further data and experience is needed to better elucidate its natural history and prognosis
🔓
#OpenAccess
at👉
@adegottardi
@CHUVLausanne
@docberza
#LiverTwitter
3
27
55
Are patients with
#HCC
& portal vein tumour thrombosis candidates for
#LiverTransplantation
?
Read about the arguments for🆚against here in this debate👉
#LiverTwitter
0
19
55
Non-selective beta-blockers impair global circulatory homeostasis and renal function in cirrhotic patients with refractory ascites
#Cirrhosis
0
26
53
EASL
#CPGs
on the management of
#HepaticEncephalopathy
✅Evidence-based answers
✅definition
✅diagnosis
✅differential diagnosis & treatment
➡️formulated in PICO format as much as possible
Full text👉
@EASLnews
@EASLedu
#LiverTwitter
1
23
53
New Review "Combined hepatocellular-cholangiocarcinoma: An update"
Read at
#WorldCholangiocarcinomaDay
#livercancer
0
15
54
Long-term albumin treatment⬆️survival in ascites. This study shows that 1⃣ 1-month on-treatment serum albumin levels predict survival and can be used to guide therapy 2⃣ Albumin of 4 g/dl @ 1-month is linked to better outcomes.
#livertwitter
#cirrhosis
0
23
53
🆕Article in press❕
Multidrug-resistant bacterial infections after liver transplantation: prevalence, impact, and risk factors
Read it here👉
#LiverTwitter
0
18
54
🆕Article in press❕
Nomenclature, Diagnosis and Management of Drug-induced Autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report
Read it here👉
#LiverTwitter
0
25
53
In honor of the 2020
#NobelPrize
for the discovery of the Hepatitis C virus, read in this JHEP review how Michael Houghton describes the work that lead Houghton & his colleagues Qui-Lim Choo, George Kuo and Daniel Bradley to identify
#HCV
#openaccess
at .
1
25
53
Worldwide study:
Corticosteroids improve 30-day survival among patients with severe alcohol-associated
#hepatitis
, especially with MELD scores between 25 and 39
By
@juanpabloarab
&
@LuisAntonioDiaz
& colleagues➡️
0
21
52